meddevicedb.com FDA Device Reference

BLACKROCK NEUROPORT BIOPOTENTIAL SIGNAL PROCESSING SYSTEM

K090957 Class II Abbreviated
Decision Date
2009-05-28
Sponsor / Applicant
I2s Micro Implantable Systems, LLC

Technical Specification

510(k) Submission ID K090957
Product Code GWL
Medical Specialty / Panel Neurology
Regulation Citation 21 CFR 882.1835
Decision Date 2009-05-28
Clearance Pathway Abbreviated

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

BLACKROCK NEUROPORT BIOPOTENTIAL SIGNAL PROCESSING SYSTEM received FDA 510(k) clearance under submission number K090957, sponsored by I2s Micro Implantable Systems, LLC. The device was reviewed via the Abbreviated premarket notification pathway and assigned to the Neurology review panel. The statutory decision date of record is 2009-05-28.

Classification & Regulation

This clearance is catalogued under FDA product code GWL and 21 CFR 882.1835, within the Neurology review panel as a Class II device.